Business
Ocumetics Achieves Key Milestone: Laboratory Testing Confirms Accommodative Power Target was Successfully Achieved in Preparation for First-in-Human Trials
(TheNewswire) Calgary, Alberta – TheNewswire - May 8, 2025 - Ocumetics Tec...
About this update from Ocumetics Technology Corp
[{"type":"text","content":"Ocumetics Achieves Key Milestone: Laboratory Testing Confirms Accommodative Power Target was Successfully Achieved in Preparation for First-in-Human Trials\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Calgary, Alberta –\n \n\n TheNewswire -\n \n\n May 8, 2025\n \n - Ocumetics Technology\nCorp\n \n .\n \n (“Ocumetics” or the\n“Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in\nadvanced ophthalmic technology, is pleased to announce\n \n a significant breakthrough in its development of\nnext-generation intraocular lens technology. In recent laboratory\ntesting, the Company successfully demonstrated accommodative power\nchange using 3D-printed moulded lenses under simulated ciliary body\ncompression conditions - marking a pivotal step forward in the pursuit\nof restoring youthful vision.  Accommodative power refers to the\neye’s ability to focus between near and far distances following lens\nreplacement surgery.\n \n\n\n\n Dean Burns, CEO of Ocumetics, stated: “These results\nrepresent a critical milestone for Ocumetics and for the future of\nophthalmology. The data supports our confidence in the platform and\nstrengthens our commitment to delivering a lens that not only corrects\nvision but restores the natural focusing ability lost with age. Our\nnext steps will continue to focus on preparing for our first-in-human\nstudies, planned for summer 2025.”\n \n\n\n\n The testing was conducted using Ocumetics’ Lens\nAnalyzer (IOLA) bench testing platform. By simulating theoretical\nciliary body pressures, researchers were able to evaluate the lens’\nquality and ability to respond dynamically - mimicking the natural\nprocess of accommodation in the human eye. The results confirm that\nthe moulded lens design delivers the accommodative response necessary\nto move forward confidently toward human trials.\n \n\n\n\n Dr. Garth Webb, Founder and Chief Scientific Officer of\nOcumetics, commented on the breakthrough: “This achievement\nvalidates years of innovation and perseverance. Demonstrating\nmeasurable accommodative power in a laboratory setting using our\nmoulded lens design confirms the foundational science behind the\nOcumetics Lens. We are now closer than ever to redefining how we\napproach vision restoration....